Further criteria were time interval between symptom onset and MRI examination ≤9 hours in view of interventional studies like AXIS or DIAS III/IV, as well as mild to moderate stroke with NIHSS up to 7 [11], [12] with or without t-PA therapy. The gene discussed is PLAT; the disease is stroke disorder.